What Researchers Did
Researchers conducted a systematic review and meta-analysis of 27 randomized clinical trials involving 2250 participants to assess the efficacy and safety of hyperbaric oxygen therapy for post-stroke depression.
What They Found
Patients receiving hyperbaric oxygen therapy had a significantly higher response rate (69.4% vs 51.2%, odds ratio = 2.51) and significantly reduced Hamilton Depression scores (weighted mean difference = -4.33 for HAMD-17). Additionally, HBOT improved neurological deficit scores (e.g., NIHSS weighted mean difference = -2.77) and physical disability (Barthel Index weighted mean difference = 10.68).
What This Means for Canadian Patients
For Canadian patients experiencing post-stroke depression, hyperbaric oxygen therapy could potentially offer an effective treatment option to improve mood and functional recovery. However, further research specific to the Canadian healthcare context would be needed to confirm its applicability and availability.
Canadian Relevance
This study does not have a direct Canadian connection as none of the included trials or authors are identified as Canadian.
Study Limitations
A limitation of this meta-analysis is the potential for heterogeneity among the included studies and the quality of the primary research from which data was extracted.